log in
Print | Back

Patterson Belknap Webb & Tyler LLP

Benjamin F. Jackson

Benjamin F. Jackson

Associate

Patterson Belknap Webb & Tyler LLP
New York, U.S.A.

tel: 212-336-2255
Send an Email

Local Time: Thu. 01:45

Profile

Benjamin F. (“Ben”) Jackson is an associate in the Firm's Litigation department. He has experience in complex commercial litigation with a focus on antitrust, intellectual property litigation, and white collar investigations. Mr. Jackson also maintains an active and varied pro bono practice. He currently serves as a member of the Banking Law Committee of the New York City Bar Association. 

From 2015 to 2016, Mr. Jackson served as a law clerk to the Hon. Robert D. Sack of the United States Court of Appeals for the Second Circuit. From 2014 to 2015, he served as a law clerk to the Hon. Katherine B. Forrest of the United States District Court for the Southern District of New York. Before attending law school, he was a consultant in the financial services practice of a global strategy consulting firm.

Representative Matters

Complex Commercial Litigation

  • Defense of a European bank in an industry-wide investigation and private class action asserting antitrust and related contract claims based on alleged collusion and manipulation of a benchmark rate for interest rate swaps and swaptions.
  • Defense of a leading contact lens manufacturer in a nationwide antitrust class action involving allegations of anticompetitive pricing.
  • Defend innovator pharmaceutical company against antitrust claims brought by biosimilar manufacturer and class action plaintiffs relating to pricing and contracting practices for the innovator’s blockbuster biologic drug.

Intellectual Property

  • Plaintiff-side representation of a university and a scientist in an arbitration proceeding concerning the inventorship of a breakthrough biotechnology.
  • Representation of an innovator pharmaceutical company in connection with patent claims against the foreign manufacturer of a biosimilar version of the innovator’s blockbuster drug.

White Collar Defense and Investigations

  • Defense of an executive of a foreign division of a Fortune 500 company in a Foreign Corrupt Practices Act (FCPA) investigation conducted by the U.S. Department of Justice.
  • Representation of a medical device manufacturer in a fraud and False Claims Act investigation conducted by  the U.S. Department of Justice.
  • Representation of an individual real estate developer in a public integrity investigation conducted by the U.S. Department of Justice.
  • Defense of a real estate development and management company in a securities fraud investigation conducted by the Manhattan District Attorney’s Office.
  • Representation of a commercial and residential real estate company in a campaign finance investigation conducted by a state commission.

Pro Bono

  • Served as co-lead trial counsel in federal jury trial of former Rikers Island inmate’s excessive force claims against four individual correction officers.
  • Plaintiff-side representation (in conjunction with the Legal Aid Society) of the New York City Council and several public housing tenants’ organizations in a lawsuit that successfully prevented the New York City Housing Authority (NYCHA) from leasing land within eight NYCHA communities to allow for the construction of market-rate housing without following the procedures mandated by state law.

Bar Admissions

  • U.S. District Court, Southern and Eastern Districts of New York
  • New York

Education

  • Harvard Law School (J.D., magna cum laude, 2013)
    • Forum Chair, Harvard Law Review
    • Best Overall Team and Best Brief, Ames Moot Court Competition
  • Washington University in St. Louis (A.B., summa cum laude, 2008)
    • Editor in Chief, Washington University Political Review
    • Arnold J. Lien Honorary Scholar
Areas of Practice
Professional Career

Professional Activities and Experience

MEMBERSHIPS: New York City Bar Association (Banking Law Committee); American Bar Association



SPEAKING ENGAGEMENTS: “Cost-Effective and Time-Efficient Commercial Litigation in New York’s Commercial Division,” Bloomberg BNA Webinar (March 26, 2018)



Articles

Fed. Circ. Case May Change Biosimilar IPR Strategy
Patterson Belknap Webb & Tyler LLP, April 2018

 Biosimilar developers have been aggressive in filing petitions for inter partesreviews of biologics patents before the Patent Trial and Appeal Board, many ofthem preceding the filing of a marketing application. Such early IPRs are attractiveto biosimilar makers, because they provide a chance to challenge innovator patentsyears before the biosimilar maker files a marketing application with the U.S. Foodand Drug Administration...

Additional Articles


WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2019